Small interfering RNAs containing full 2′-O-methylribonucleotide- modified sense strands display Argonaute2/eIF2C2-dependent activity

RNA

Volumn 12, Issue 1, 2006, Pages 163-176

  Kraynack, Bryan A ^a   Baker, Brenda F ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

2 OMe RNA; Anti sense; RNA; Small interfering

Indexed keywords

2' O METHYLRIBONUCLEOTIDE; BIOTIN; DOUBLE STRANDED RNA; NUCLEOTIDE DERIVATIVE; RNA INDUCED SILENCING COMPLEX; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODIFICATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA ANALYSIS; RNA DEGRADATION; RNA SEQUENCE; RNA STRUCTURE; STRUCTURE ANALYSIS;

GENE SILENCING; HELA CELLS; HUMANS; NUCLEOTIDES; PEPTIDE INITIATION FACTORS; RNA, COMPLEMENTARY; RNA, SMALL INTERFERING; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSFECTION;

EID: 29844452007     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.2150806     Document Type: Article

References (52)

1. Allerson, C.R., Sioufi, N., Jarres, R., Prakash, T.P., Naik, N., Berdeja, A., Wanders, L., Griffey, R.H., Swayze, E.E., and Bhat, B. 2005. Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J. Med. Chem. 48: 901-904.
2. Altmann, K.H., Fabbro, D., Dean, N.M., Geiger, T., Monia, B.P., Muller, M., and Nicklin, P. 1996. Second-generation antisense oligonucleotides: Structure-activity relationships and the design of improved signal-transduction inhibitors. Biochem. Soc. Trans. 24: 630-637.
3. Amarzguioui, M., Holen, T., Babaie, E., and Prydz, H. 2003. Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res. 31: 589-595.
4. Bennett, C.F. and Cowsert, L.M. 1999. Antisense oligonucleotides as a tool for gene functionalization and target validation. Biochim. Biophys. Acta 1489: 19-30.
5. Braasch, D.A. and Corey, D.R. 2002. Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry 41: 4503-4510.
6. Braasch, D.A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M.A., and Corey, D.R. 2003. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 42: 7967-7975.
7. Caplen, N.J., Parrish, S., Imani, F., Fire, A., and Morgan, R.A. 2001. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. 98: 9742-9747.
8. Chendrimada, T.P., Gregory, R.I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, K., and Shiekhattar, R. 2005. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436: 740-744.
9. Chiu, Y.L. and Rana, T.M. 2003. siRNA function in RNAi: A chemical modification analysis. RNA 9: 1034-1048.
10. Crooke, S.T. 1999. Molecular mechanisms of action of antisense drugs. Biochim. Biophys. Acta 1489: 31-44.
11. Cummins, L.L., Owens, S.R., Risen, L.M., Lesnik, E.A., Freier, S.M., McGee, D., Guinosso, C.J., and Cook, P.D. 1995. Characterization of fully 2′-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity. Nucleic Acids Res. 23: 2019-2024.
12. Czauderna, F., Fechtner, M., Dames, S., Aygun, H., Klippel, A., Pronk, G.J., Giese, K., and Kaufmann, J. 2003. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31: 2705-2716.
13. de Fougerolles, A., Manoharan, M., Meyers, R., and Vornlocher, H.P. 2005. RNA interference in vivo: Toward synthetic small inhibitory RNA-based therapeutics. Methods Enzymol. 392: 278-296.
14. Ding, H., Schwarz, D.S., Keene, A., el Affar, B., Fenton, L., Xia, X., Shi, Y., Zamore, P.D., and Xu, Z. 2003. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2: 209-217.
15. Eckstein, F. 2000. Phosphorothioate oligodeoxynucleotides: What is their origin and what is unique about them? Antisense Nucleic Acid Drug Dev. 10: 117-121.
16. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. 2001a. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
17. Elbashir, S.M., Martinez, J., Patkaniowska, A., Lendeckel, W., and Tuschl, T. 2001b. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20: 6877-6888.
18. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., and Mello, C.C. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
19. Freier, S.M. and Altmann, K.H. 1997. The ups and downs of nucleic acid duplex stability: Structure-stability studies on chemically-modified DNA:RNA duplexes. Nucleic Acids Res. 25: 4429-4443.
20. Geary, R.S., Yu, R.Z., and Levin, A.A. 2001. Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides. Curr. Opin. Investig. Drugs 2: 562-573.
21. Grunweller, A., Wyszko, E., Bieber, B., Jahnel, R., Erdmann, V.A., and Kurreck, J. 2003. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res. 31: 3185-3193.
22. Hammond, S.M., Bernstein, E., Beach, D., and Hannon, G.J. 2000. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404: 293-296.
23. Hammond, S.M., Boettcher, S., Caudy, A.A., Kobayashi, R., and Hannon, G.J. 2001a. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293: 1146-1150.
24. Hammond, S.M., Caudy, A.A., and Hannon, G.J. 2001b. Post-transcriptional gene silencing by double-stranded RNA. Nat. Rev. Genet. 2: 110-119.
25. Hannon, G.J. 2002. RNA interference. Nature 418: 244-251.
26. Harborth, J., Elbashir, S.M., Vandenburgh, K., Manninga, H., Scaringe, S.A., Weber, K., and Tuschl, T. 2003. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 13: 83-105.
27. Jackson, A.L., Bartz, S.R., Schelter, J., Kobayashi, S.V., Burchard, J., Mao, M., Li, B., Cavet, G., and Linsley, P.S. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21: 635-637.
28. Khvorova, A., Reynolds, A., and Jayasena, S.D. 2003. Functional siRNAs and miRNAs exhibit strand bias. Cell 115: 209-216.
29. Layzer, J.M., McCaffrey, A.P., Tanner, A.K., Huang, Z., Kay, M.A., and Sullenger, B.A. 2004. In vivo activity of nuclease-resistant siRNAs. RNA 10: 766-771.
30. Lee, Y.S., Nakahara, K., Pham, J.W., Kim, K., He, Z., Sontheimer, E.J., and Carthew, R.W. 2004. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 117: 69-81.
31. Liu, Q., Rand, T.A., Kalidas, S., Du, F., Kim, H.E., Smith, D.P., and Wang, X. 2003. R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway. Science 301: 1921-1925.
32. Liu, J., Carmell, M.A., Rivas, F.V., Marsden, C.G., Thomson, J.M., Song, J.J., Hammond, S.M., Joshua-Tor, L., and Hannon, G.J. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305: 1437-1441.
33. Lubini, P., Zurcher, W., and Egli, M. 1994. Stabilizing effects of the RNA 2′-substituent: Crystal structure of an oligodeoxynucleotide duplex containing 2′-O-methylated adenosines. Chem. Biol. 1: 39-45.
34. Manoharan, M. 2004. RNA interference and chemically modified small interfering RNAs. Curr. Opin. Chem. Biol. 8: 570-579.
35. Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R., and Tuschl, T. 2002. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110: 563-574.
36. Martinez, J., Patkaniowska, A., Elbashir, S.M., Harborth, J., Hossbach, M., Urlaub, H., Meyer, J., Weber, K., Vandenburgh, K., Manninga, H., et al. 2003. Analysis of mammalian gene function using small interfering RNAs. Nucleic Acids Res. Suppl.: 333.
37. McManus, M.T. and Sharp, P.A. 2002. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3: 737-747.
38. Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., and Tuschl, T. 2004. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15: 185-197.
39. Nykanen, A., Haley, B., and Zamore, P.D. 2001. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107: 309-321.
40. Peck, M.L. and Herschlag, D. 1999. Effects of oligonucleotide length and atomic composition on stimulation of the ATPase activity of translation initiation factor elF4A. RNA 5: 1210-1221.
41. Pham, J.W., Pellino, J.L., Lee, Y.S., Carthew, R.W., and Sontheimer, E.J. 2004. A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila. Cell 117: 83-94.
42. Rand, T.A., Ginalski, K., Grishin, N.V., and Wang, X. 2004. Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity. Proc. Natl. Acad. Sci. 101: 14385-14389.
43. Ravichandran, L.V., Dean, N.M., and Marcusson, E.G. 2004. Use of antisense oligonucleotides in functional genomics and target validation. Oligonucleotides 14: 49-64.
44. Rivas, F.V., Tolia, N.H., Song, J.J., Aragon, J.P., Liu, J., Hannon, G.J., and Joshua-Tor, L. 2005. Purified Argonaute2 and an siRNA form recombinant human RISC. Nat. Struct. Mol. Biol. 12: 340-349.
45. Scacheri, P.C., Rozenblatt-Rosen, O., Caplen, N.J., Wolfsberg, T.G., Umayam, L., Lee, J.C., Hughes, C.M., Shanmugam, K.S., Bhattacharjee, A., Meyerson, M., et al. 2004. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. 101: 1892-1897.
46. Schubert, S., Grunweller, A., Erdmann, V.A., and Kurreck, J. 2005. Local RNA target structure influences siRNA efficacy: Systematic analysis of intentionally designed binding regions. J. Mol. Biol. 348: 883-893.
47. Schwarz, D.S., Hutvagner, G., Du, T., Xu, Z., Aronin, N., and Zamore, P.D. 2003. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115: 199-208.
48. Semizarov, D., Frost, L., Sarthy, A., Kroeger, P., Halbert, D.N., and Fesik, S.W. 2003. Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl. Acad. Sci. 100: 6347-6352.
49. Song, J.J., Smith, S.K., Hannon, G.J., and Joshua-Tor, L. 2004. Crystal structure of Argonaute and its implications for RISC Slicer Activity. Science 305: 1434-1437.
50. Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. 2004. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432: 173-178.
51. Vickers, T.A., Koo, S., Bennett, C.F., Crooke, S.T., Dean, N.M., and Baker, B.F. 2003. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem. 278: 7108-7118.
52. Wu, H., Lima, W.F., Zhang, H., Fan, A., Sun, H., and Crooke, S.T. 2004. Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. J. Biol. Chem. 279: 17181-17189.